Not Yet Operational
Patients who possess a physician’s recommendation may legally obtain up to three ounces of herbal medical cannabis provided by state licensed dispensaries. A registered qualifying patient may not purchase or have purchased by a registered designated caregiver more than the maximum concentration or amount of tetrahydrocannabinol permitted in a thirty - day period. The maximum concentration or amount of tetrahydrocannabinol permitted in a thirty - day period for a cannabinoid concentrate or medical cannabinoid product, or the cumulative total of both, is two thousand milligrams. Patients must have a specific certification from their physician in order to consume herbal cannabis formulations via combustion. Otherwise patients are permitted only to obtain cannabis infused tinctures, capsules, patches, or topical. Edible products are not defined as a “medical cannabinoid product” under the act.
No. This provision was removed by lawmakers by the passage of SB 2344.
Yes, but no more than two producers and eight dispensaries.
The program’s rules are specified in Senate Bill 2344. The program is expected to be operational by summer 2018.